Bacteriophages as nanocarriers for targeted drug delivery and enhanced therapeutic effects
Stephen Chijioke EmenchetaDepartment of Pharmaceutical Microbiology and Biotechnology, University of Nigeria, Nsukka, 410001, NigeriaAdaeze Linda OnugwuDepartment of Pharmaceutics, University of Nigeria, Nsukka, 410001, NigeriaChisom F. KaluDepartment of Pharmaceutical Microbiology and Biotechnology, University of Nigeria, Nsukka, 410001, NigeriaPatience N. EzinkwoDepartment of Medicine and Surgery, University Teaching Hospital, University of Nigeria, Enugu Campus, 410001, NigeriaOsita C. EzeDepartment of Pharmaceutical Microbiology and Biotechnology, University of Nigeria, Nsukka, 410001, NigeriaMarta M. D. C. VilaVBlab - Laboratory of Bacterial Viruses, University of Sorocaba, 18023-000 Sorocaba, SP, BrazilVictor M. BalcãoDepartment of Biology and CESAM, University of Aveiro, Campus Universitário de Santiago, P-3810-193, Aveiro, PortugalAnthony A. AttamaDepartment of Pharmaceutics, University of Nigeria, Nsukka, 410001, NigeriaEbele OnuigboDepartment of Pharmaceutical Microbiology and Biotechnology, University of Nigeria, Nsukka, 410001, Nigeria
2024en
ABI
Аннотация
The bioengineering of phages to display ligands leads to specific targeting, reduced toxicity, enhanced cellular uptake of an incorporated drug/gene and, ultimately, increased therapeutic efficacy.
Перевод пока недоступен
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0